On April 15th, the Food and Drug Administration will begin accepting applicants through its new Expedited Access Premarket Approval Application for Unmet Medical Needs for Life Threatening or Irreversibly Debilitating Diseases or Conditions (“Expedited Access PMA” or “EAP”). Read more
123 S. Broad Street, Suite 1350
Philadelphia, PA 19109
T 215.627.4122
F 215.627.4335
909 Davis Street, Suite 470
Evanston, IL 60201
T 312.584.0240
F 215.627.4335
Blütenstraße 15
80799 München
Germany
T +49.(0)178.876.7277
We conduct rigorous research to optimize the usability, safety, and customer appeal of products. Contact us to discuss a project today.
